Oral arguments for a lawsuit challenging the new ban on physician-owned hospitals will be heard on Sept. 29 at U.S. District Court in Tyler, Texas.
Legal & Regulatory Issues
Charles Allen, CEO of Crowe Horwath, a nationwide accounting firm, discusses the effect of healthcare reform on five key groups:
CMS has achieved a 1 percent reduction in Medicare Advantage premiums for next year by denying proposed rate increases and benefit cuts in about 14 percent of bids from private insurers in the program, according to a report by the…
A whole bevy of consumer-friendly provisions in the healthcare reform law kick in on Sept. 23, six months after the legislation was signed, according to a report by Kaiser Health News. Here are a six key points about the new…
HHS is calling on states to enroll nearly 5 million uninsured children, but some states are facing budget crises that are forcing them to pull back on commitments, according to a report by American Medical News.
Advertisement
Republican Congressional leaders have stated at least six ways they could chip away at the healthcare reform law after the election, when they are expected to win the House and add Senate seats, according to reports in the New York…
Florida gubernatorial candidate and former Columbia/HCA CEO Rick Scott claims he would have stopped the hospital company from committing healthcare fraud that violated federal anti-kickback law if he had been aware of it, despite annual reports suggesting he was, in…
The president of the American Academy of Nursing, in a commentary article published by The Baltimore Sun, pushes for more states, including Maryland, to opt out of the federal rule requiring CRNAs to receive anesthesiologist supervision when providing care to…
The New York Times has published a few letters to the editor discussing the publication's editorial column "Who Should Provide Anesthesia Care?" which centers around the ongoing debate about whether a CRNA can deliver anesthetics without the supervision of anesthesiologist.
The Drug Enforcement Administration is looking to designate propofol as a "scheduled" drug, which would tighten restrictions on the drug's distribution and use, according to an Anesthesiology News report.